Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyroglobulin immunoreactivity in lymph node histiocytes: a potential diagnostic pitfall.

L Venkatraman1, P Maxwell, W G McCluggage

  • 1Department of Pathology, Royal Group of Hospitals Trust, Grosvenor Road, Belfast BT12 6BL, Northern Ireland, UK. glenn.mccluggage@bll.n-i.nhs.uk

Journal of Clinical Pathology
|April 18, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

QuPath: The global impact of an open source digital pathology system.

Computational and structural biotechnology journal·2021
Same author

HYPERTENSION TARGETS - MOVING THE GOALPOSTS AGAIN!

The Ulster medical journal·2019
Same author

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2019
Same author

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Training in molecular cytopathology testing.

Cytopathology : official journal of the British Society for Clinical Cytology·2017

Thyroglobulin (Tg) staining in lymph nodes near thyroid cancer is common. This staining in sinus histiocytes is not metastatic tumor but rather uptake of released Tg, important for pathologists to note.

Area of Science:

  • Surgical pathology
  • Endocrine pathology
  • Oncology

Background:

  • Thyroglobulin (Tg) is a key protein produced by thyroid follicular cells.
  • Immunoreactivity for Tg in lymph nodes adjacent to thyroid malignancies has been observed.
  • The significance and frequency of this finding require further investigation.

Purpose of the Study:

  • To determine the prevalence of thyroglobulin immunoreactivity in regional lymph nodes of patients with thyroid malignancy.
  • To differentiate Tg-positive histiocytes from metastatic thyroid cancer in lymph nodes.

Main Methods:

  • Analysis of 87 lymph nodes from 21 thyroid malignancy cases (papillary, follicular, medullary, squamous, anaplastic carcinomas).
  • Inclusion of 11 control lymph nodes from patients without thyroid disease.

Related Experiment Videos

  • Immunohistochemical staining using a monoclonal antibody against thyroglobulin.
  • Main Results:

    • 32 of 87 lymph nodes (36.8%) showed positive Tg staining in sinus histiocytes.
    • Four additional cases exhibited Tg staining within lymphatic channels.
    • Positivity was found in at least one node in 15 of 21 cases (71.4%).
    • No positivity was observed in control lymph nodes.
    • No correlation between primary tumor size and Tg positivity was found.

    Conclusions:

    • Thyroglobulin immunoreactivity in sinus histiocytes of draining lymph nodes is a common finding in thyroid tumors.
    • This positivity likely results from histiocytes uptaking Tg released from damaged thyroid follicles.
    • Pathologists must be aware of this phenomenon to avoid misinterpreting it as metastatic disease.